Amae Health Secures $25M Series B to Revolutionize care for Severe Mental Illness
san Francisco, CA - November 11, 2025 - Amae Health, a pioneering startup dedicated to transforming the landscape of severe mental illness treatment, today announced the successful completion of a $25 million Series B funding round. This meaningful investment positions the company for rapid expansion and further development of its innovative, integrated care model.
Addressing a Critical Gap in Healthcare
Severe mental illnesses – including schizophrenia, bipolar disorder, major depressive disorder, and borderline personality disorder – represent a profound public health challenge. Individuals affected often face significant stigma, limited access to specialized care, and exclusion from vital research. Traditional healthcare systems, frequently enough burdened by competing demands, struggle to deliver the comprehensive, coordinated support these patients require. Amae Health was founded to directly address this critical gap.
“Peopel living with severe mental illness are among the most underserved and stigmatized in our healthcare system,” explains Stas Sokolin, CEO of Amae Health. ”They deserve access to research-backed, high-quality care that addresses not only their medical needs but also the complex social determinants impacting their well-being. We’re building a system designed to provide exactly that.”
A Holistic, Integrated Care Model
Amae Health distinguishes itself through a uniquely holistic approach to outpatient care.The company partners with leading health systems – including NewYork-Presbyterian, Cedars-Sinai, and Stanford Health Care – to deliver a comprehensive suite of services. Patients benefit from a dedicated care team comprised of:
* psychiatrists: Providing expert diagnosis and medication management.
* Therapists: Offering evidence-based psychotherapy.
* Primary Care Physicians: addressing overall physical health needs.
* Dietitians: Supporting nutritional well-being.
* Health Coaches: Promoting healthy lifestyle choices.
* Peer Mentors: Providing invaluable support and shared experience.
* Clinical Care Coordinators: Ensuring seamless care navigation and communication.
This collaborative model ensures patients receive truly integrated care, addressing the interconnectedness of mental and physical health, as well as social and environmental factors.
Leveraging Technology for Personalized Treatment
Amae health isn’t just redefining how care is delivered, but also how it’s informed. The company is developing a elegant, AI-driven platform designed to enhance clinical decision-making and personalize treatment plans. Key features include:
* Unified Patient Data: A centralized dashboard consolidating all relevant patient details.
* Real-Time Health Monitoring: Tracking key health indicators and identifying potential issues proactively.
* Symptom Pattern Recognition: Utilizing AI to detect subtle changes in symptom presentation, enabling timely intervention.
This technology empowers providers to deliver more targeted, effective care, ultimately improving patient outcomes.
Demonstrable Results: Improving Outcomes and Reducing Readmissions
amae Health’s innovative approach is already yielding notable results. The company reports a significant reduction in 30-day hospital readmissions – achieving a rate of approximately 4%, compared to the national average of 23%. Moreover, measurement-based care has demonstrated ample improvements in key symptom areas:
* Mania: 76% enhancement
* Psychosis: 61% improvement
* suicidality: 49% improvement
these data points underscore the potential of Amae Health’s model to substantially improve the lives of individuals struggling with severe mental illness.
Expanding Access and Advancing Research
The $25 million Series B funding, led by Altos Ventures with participation from Quiet Capital, Bling Capital, Cedars-Sinai Ventures, Healthier Capital, and 8VC, will fuel several key initiatives:
* Clinic Expansion: Amae Health will expand its physical footprint, bringing its specialized care to more communities across the country. Current clinics are located in California, North Carolina, and New York.
* Academic Partnerships: strengthening collaborations with leading academic medical centers to drive research and innovation.
* Research Focus: Dedicated investment in research focused on schizophrenia, bipolar disorder, and treatment-resistant depression.
* Platform Development: Continued refinement and expansion of the AI-driven platform to further personalize and optimize care.
“Amae is advancing a model of care that prioritizes clinical excellence and compassionate, patient-centered services,” says Dr. itai Danovitch, Chair of the Department of Psychiatry and Behavioral Neurosciences at Cedars-Sinai Medical Center. “By combining an outstanding team of clinicians with a thoughtful approach
